Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva Announces New Org Structure, Leadership Changes | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Here's Why Teva Pharmaceutical Industries (NYSE:TEVA) Is Weighed Down By Its Debt Load - Simply Wall St News
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Pharmaceutical S&P rating outlook changed to stable | Seeking Alpha
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Beats Analysts on Second Quarter Operating Income, Revenues | Ctech
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva | Partnership | Direct Relief
Jose Lassalle - Finance Manager - Teva Pharmaceuticals | LinkedIn
Teva Reports Third Quarter 2022 Financial Results
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva profit plummets, stock slides | Ctech
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Michael (Mickey) Ben Moshe - VP Finance, Corporate Treasury @ Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote - YouTube
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Ran Sagiv - Senior Director, Corporate Finance at Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
